Skip to contentSkip to filters

We use cookies for analytics.

Grant, Call number PAR-25-353

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

National Institutes of Health

  • United States
  • Institution applies
  • Psychiatry, Pharmacology and
Related content

About

This multi-project cooperative agreement supports development of candidate drugs and neurostimulation approaches for mental disorders, substance use disorders or alcohol use disorder. Teams can also develop tools for assessing how treatments engage biological targets.

Topics

Eligibility

Covers: Multi-project U19 cooperative agreement for discovery, preclinical development and proof-of-concept studies.

The lead applicant must be an eligible US organization.

simpler.grants.govgrants.nih.gov

Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. The lead applicant must be an eligible US organization.

Source: simpler.grants.gov